{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T18:43:01Z","timestamp":1774982581852,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,4,9]],"date-time":"2010-04-09T00:00:00Z","timestamp":1270771200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s00404-010-1429-x","type":"journal-article","created":{"date-parts":[[2010,4,8]],"date-time":"2010-04-08T03:30:49Z","timestamp":1270697449000},"page":"319-325","source":"Crossref","is-referenced-by-count":29,"title":["Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients"],"prefix":"10.1007","volume":"282","author":[{"given":"Ensieh Shahrokh","family":"Tehraninejad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roya","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Batool","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fedieh","family":"Haghollahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzieh","family":"Ataie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,9]]},"reference":[{"key":"1429_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(16)58017-0","volume":"65","author":"RP Buyalos","year":"1996","unstructured":"Buyalos RP, Lee CT (1996) Polycystic ovary syndrome: pathophysiology and outcome with in vitro fertilization. Fertil Steril 65:1","journal-title":"Fertil Steril"},{"key":"1429_CR2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0015-0282(16)55794-X","volume":"59","author":"R Hamburg","year":"1993","unstructured":"Hamburg R, Berkovitz D, Frachi J, Feldbery D, Ashkenazi J, Ben-Rafael Z (1993) Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome. Fertil Steril 59:527\u2013531","journal-title":"Fertil Steril"},{"key":"1429_CR3","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0015-0282(16)56287-6","volume":"60","author":"R Homburg","year":"1993","unstructured":"Homburg R, Berkowitz D, Hervy T, Feldberg D, Ashkenazi J, Ben-rafael Z (1993) Invitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome. Fertil Steril 60:858","journal-title":"Fertil Steril"},{"issue":"4","key":"1429_CR4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/humupd\/dml001","volume":"12","author":"BC Tarlatzis","year":"2006","unstructured":"Tarlatzis BC, Fauser BC, Kolibianakis EM, Diedrich K, Rombauts L, Devroey P (2006) GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update 12(4):333\u2013340","journal-title":"Hum Reprod Update"},{"issue":"9","key":"1429_CR5","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/humrep\/deh375","volume":"19","author":"JL Hwang","year":"2004","unstructured":"Hwang JL, Sew KM, Lin YH, Huang LW, Hsieh BC, Tsai YL et al (2004) Ovarian stimulation by concomitant administration of Cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study. Hum Reprod 19(9):1993\u20132000","journal-title":"Hum Reprod"},{"issue":"1","key":"1429_CR6","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1093\/humrep\/dem270","volume":"22","author":"YA Huirne","year":"2007","unstructured":"Huirne YA, Homburg R, Lambalk CB (2007) Are GnRH antagonists comparable to agonists for use in IVF? Hum Reprod 22(1):2805\u20132813","journal-title":"Hum Reprod"},{"key":"1429_CR7","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/humrep\/12.11.2359","volume":"12","author":"MA Damario","year":"1997","unstructured":"Damario MA, Barmat L, Liu HC, Davis OK, Rosenwaks Z (1997) Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in vitro fertilization outcome in high responder patients. Hum Reprod 12:2359\u20132365","journal-title":"Hum Reprod"},{"key":"1429_CR8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0015-0282(16)60906-8","volume":"52","author":"MD Damewood","year":"1989","unstructured":"Damewood MD, Shen W, Zacur HA, Schlaff WD, Rock JA, Wallach EE (1989) Disappearance of exogenously administered human chorionic gonadotrophin. Fertil Steril 52:398\u2013400","journal-title":"Fertil Steril"},{"key":"1429_CR9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0015-0282(16)58404-0","volume":"66","author":"F Olivennes","year":"1996","unstructured":"Olivennes F, Fanchin R, Bouchard P, Taieb J, Frydman R (1996) Triggering of ovulation by a gonadotropin-releasing hormone (GnRH) agonist in patients pretreated with a GnRH antagonist. Fertil Steril 66:151\u2013153","journal-title":"Fertil Steril"},{"key":"1429_CR10","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus workshop group (2004) Revised 2003 Consensus on diagnostic Criteria and Long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19\u201325","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"1429_CR11","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF01133388","volume":"3","author":"JM Cummins","year":"1986","unstructured":"Cummins JM, Breen TM, Harrison KL, Shaw JM, Wilson LM, Hennessey JF (1986) A formula for scoring human embryo growth rates in invitro fertilization: its value in predicting pregnancy and in comparison with visual estimates of embryo quality. J In Vitro Fertil Embryo Transfer 3:284\u2013295","journal-title":"J In Vitro Fertil Embryo Transfer"},{"issue":"6","key":"1429_CR12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00006254-198906000-00004","volume":"44","author":"A Golan","year":"1989","unstructured":"Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E (1989) Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv 44(6):430\u2013440","journal-title":"Obstet Gynecol Surv"},{"issue":"7","key":"1429_CR13","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/humrep\/15.7.1490","volume":"15","author":"G Borm","year":"2000","unstructured":"Borm G, Mannaerts B (2000) Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European orgalutran study group. Hum Reprod 15(7):1490\u20131498","journal-title":"Hum Reprod"},{"key":"1429_CR14","doi-asserted-by":"crossref","unstructured":"Fluker M, Grifo Y, Leader A et al, North American Ganirelix study group (2001) Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyper stimulation. Fertil steril 75(1):38\u201345","DOI":"10.1016\/S0015-0282(00)01638-1"},{"issue":"4","key":"1429_CR15","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/humrep\/16.4.644","volume":"16","author":"European and Middle East Orgalutrans Study Group","year":"2001","unstructured":"European and Middle East Orgalutrans Study Group (2001) Comparable clinical outcome using the GnRH antagonist ganirelix or along protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod 16(4):644\u2013651","journal-title":"Hum Reprod"},{"issue":"6","key":"1429_CR16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/humupd\/dml038","volume":"12","author":"EM Kolibianakis","year":"2006","unstructured":"Kolibianakis EM, Collins J, Tarlatzis BC, Devroy P, Diedrich K, Griesinger G (2006) Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update. 12(6):651\u2013671","journal-title":"Hum Reprod Update."},{"issue":"5","key":"1429_CR17","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1472-6483(10)61059-0","volume":"14","author":"HG Al-Inany","year":"2007","unstructured":"Al-Inany HG, Abou-setta Am, Aboulghar M (2007) Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review. Reprod Biomed Online 14(5):640\u2013649","journal-title":"Reprod Biomed Online"},{"issue":"8","key":"1429_CR18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10815-008-9249-7","volume":"25","author":"R Kurzawa","year":"2008","unstructured":"Kurzawa R, Ciepiela P, Baczkowski T, Safranow K, Brelik P (2008) Comparison of embryological and clinical outcome in GnRH antagonist VS GnRH agonist protocols for in vitro fertilization in PCOs non-obese patients. A prospective randomized study. J Assist Reprod Genet 25(8):365\u2013375","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"1429_CR19","first-page":"84","volume":"50","author":"M Bahceci","year":"2005","unstructured":"Bahceci M, Ulug U, Ben-scholomo I, Erden HF, Akman MA (2005) Use of a GnRH antagonist in controlled ovarian hyper stimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study. J Reprod Med 50(2):84\u201390","journal-title":"J Reprod Med"},{"issue":"1","key":"1429_CR20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","volume":"89","author":"L Engman","year":"2008","unstructured":"Engman L, Diluigi A, Schmidt D, Nulsen J, Maier D, Benadiva C (2008) The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyper stimulation syndrome: a prospective randomized controlled study. Fertil Steril 89(1):84\u201391","journal-title":"Fertil Steril"},{"issue":"4","key":"1429_CR21","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/humrep\/17.4.874","volume":"17","author":"H Al-Inany","year":"2002","unstructured":"Al-Inany H, Aboulghar M (2002) GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod 17(4):874\u2013885","journal-title":"Hum Reprod"},{"issue":"5","key":"1429_CR22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/humupd\/dmm008","volume":"13","author":"EM Kolibianakis","year":"2007","unstructured":"Kolibianakis EM, Kalogeropoulou L, Griesinger G, Papanikolaou EG, Papadimas J, Bontis J et al (2007) Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis. Hum Reprod Update 13(5):445\u2013452","journal-title":"Hum Reprod Update"},{"issue":"5","key":"1429_CR23","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S1472-6483(10)60652-9","volume":"13","author":"G Griesinger","year":"2006","unstructured":"Griesinger G, Diedrich K, Taralatzis BC, Kolibianakis EM (2006) GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyper stimulation: a meta-analysis. Reprod Biomed Online 13(5):628\u2013638","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"1429_CR24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1472-6483(10)61870-6","volume":"7","author":"E Kolibianakis","year":"2003","unstructured":"Kolibianakis E, Zikopoulos K, Albano C, Camus M, Tournaye H, Van Steirteghem A et al (2003) Reproductive outcome of polycystic ovarian syndrome patients treated with GnRH antagonists and recombinant FSH for IVF\/ICSI. Reprod Biomed Online 7(3):313\u2013318","journal-title":"Reprod Biomed Online"},{"issue":"9","key":"1429_CR25","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/humrep\/dei074","volume":"20","author":"G Ragni","year":"2005","unstructured":"Ragni G, Vegetti W, Riccaboni A, Engl B, Brigante C, Crosignani PG (2005) Comparison of GnRh agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyper stimulation syndrome. Hum Reprod 20(9):2421\u20132425","journal-title":"Hum Reprod"},{"key":"1429_CR26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.fertnstert.2005.07.1292","volume":"85","author":"Eg Papanikolaou","year":"2006","unstructured":"Papanikolaou Eg, Pozzobon C, Kolibianakis EM, Camas M, Tournage H, Fatemi HM et al (2006) Incidence and prediction of ovarian hyper stimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril 85:12\u201320","journal-title":"Fertil Steril"},{"key":"1429_CR27","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1093\/humrep\/15.9.1965","volume":"15","author":"J Itskovitz-Eldor","year":"2000","unstructured":"Itskovitz-Eldor J, Kol S, Mannaerts B (2000) Use of single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyper stimulation syndrome: short communication. Hum Reprod 15:1965\u20131968","journal-title":"Hum Reprod"},{"key":"1429_CR28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1023\/A:1026498629324","volume":"18","author":"D Yong De","year":"2001","unstructured":"De Yong D, Van Hooren EG, Macklon NS, Mannaerts BM, Fauser BC (2001) Pregnancy and birth after GnRH agonist treatment for induction of final oocyte maturation in a woman undergoing ovarian stimulation for ICSI, using a GnRH antagonist (orgalutran\/Antagon) to prevent a premature LH surge: a case report. J Assist Reprod Genet 18:30\u201333","journal-title":"J Assist Reprod Genet"},{"key":"1429_CR29","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/humrep\/dei475","volume":"21","author":"R Babayof","year":"2006","unstructured":"Babayof R, Margalioth EJ, Huleihel M, Amash A, Zylber-Haran E, Gal M et al (2006) Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial. Hum Reprod 21:1260\u20131265","journal-title":"Hum Reprod"},{"key":"1429_CR30","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/deh765","volume":"20","author":"P Humaidan","year":"2005","unstructured":"Humaidan P, Bredkjaer HE, Bungum L, Grondahi ML, Westergaard L, Anderson Cy (2005) GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study. Hum Reprod 20:1213\u20131220","journal-title":"Hum Reprod"},{"key":"1429_CR31","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1093\/humrep\/dei150","volume":"20","author":"EM Kolibianakis","year":"2005","unstructured":"Kolibianakis EM, Schultze-Mosgau A, Schorer A, Van Steirteghem A, Devroey P, Diedrich K et al (2005) A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Hum Reprod 20:2887\u20132892","journal-title":"Hum Reprod"},{"issue":"2","key":"1429_CR32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/humupd\/dmi045","volume":"12","author":"G Griesinger","year":"2006","unstructured":"Griesinger G, Diedrich K, Devroey P, Kolibianakis EM (2006) GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum Reprod Update 12(2):159\u2013168","journal-title":"Hum Reprod Update"},{"issue":"2","key":"1429_CR33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1472-6483(10)60612-8","volume":"13","author":"P Humaidan","year":"2006","unstructured":"Humaidan P, Bungum L, Bungum M, Yding Andersen C (2006) Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF\/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study. Reprod Biomed Online 13(2):173\u2013178","journal-title":"Reprod Biomed Online"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-010-1429-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-010-1429-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-010-1429-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:54:02Z","timestamp":1559051642000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-010-1429-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["1429"],"URL":"https:\/\/doi.org\/10.1007\/s00404-010-1429-x","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,9]]}}}